Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.19.3
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Series C Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Beginning balance, shares at Mar. 31, 2018 685,747        
Beginning balance, value at Mar. 31, 2018 $ 1,000 $ 176,740,000 $ (157,440,000) $ (3,975,000) $ 15,326,000
Issuance of common stock in connection with market issuance sales agreement, net of commissions, expenses and other offering costs, shares 29,710        
Issuance of common stock in connection with market issuance sales agreement, net of commissions, expenses and other offering costs, value 958,000 958,000
Stock based compensation related to issuance of common stock restricted stock grants, shares 1,764        
Stock based compensation related to issuance of common stock restricted stock grants, value 61,000 61,000
Issuance of common stock for service fees, shares 2,736        
Issuance of common stock for service fees, value 59,000 59,000
Stock-based compensation expense, net of forfeitures 811,000 811,000
Foreign currency translation adjustment (152,000) (152,000)
Net income (loss) (6,278,000) (6,278,000)
Ending balance, shares at Sep. 30, 2018 719,957        
Ending balance, value at Sep. 30, 2018 $ 1,000 178,629,000 (163,718,000) (4,127,000) 10,785,000
Beginning balance, shares at Jun. 30, 2018 714,751        
Beginning balance, value at Jun. 30, 2018 $ 1,000 178,003,000 (160,898,000) (4,477,000) 12,629,000
Issuance of common stock in connection with market issuance sales agreement, net of commissions, expenses and other offering costs, shares 2,470        
Issuance of common stock in connection with market issuance sales agreement, net of commissions, expenses and other offering costs, value 42,000 42,000
Stock based compensation related to issuance of common stock restricted stock grants, shares        
Stock based compensation related to issuance of common stock restricted stock grants, value 16,000 16,000
Issuance of common stock for service fees, shares 2,736        
Issuance of common stock for service fees, value 59,000 59,000
Stock-based compensation expense, net of forfeitures 509,000 509,000
Foreign currency translation adjustment 350,000 350,000
Net income (loss) (2,820,000) (2,820,000)
Ending balance, shares at Sep. 30, 2018 719,957        
Ending balance, value at Sep. 30, 2018 $ 1,000 178,629,000 (163,718,000) (4,127,000) 10,785,000
Beginning balance, shares at Mar. 31, 2019 2 1,316,335        
Beginning balance, value at Mar. 31, 2019 $ 2,000 184,074,000 (169,238,000) (4,349,000) 10,489,000
Cumulative adjustment resulting from adoption of ASU (59,000) (59,000)
Stock based compensation related to issuance of common stock restricted stock grants, shares 1,669        
Stock based compensation related to issuance of common stock restricted stock grants, value 29,000 29,000
Stock-based compensation expense, net of forfeitures 396,000 396,000
Foreign currency translation adjustment (96,000) (96,000)
Net income (loss) (488,000) (488,000)
Ending balance, shares at Sep. 30, 2019 2 1,318,004        
Ending balance, value at Sep. 30, 2019 $ 2,000 184,499,000 (169,785,000) (4,445,000) 10,271,000
Beginning balance, shares at Jun. 30, 2019 2 1,317,170        
Beginning balance, value at Jun. 30, 2019 $ 2,000 184,366,000 (168,582,000) (4,282,000) 11,504,000
Stock based compensation related to issuance of common stock restricted stock grants, shares 834        
Stock based compensation related to issuance of common stock restricted stock grants, value 9,000 9,000
Stock-based compensation expense, net of forfeitures 124,000 124,000
Foreign currency translation adjustment (163,000) (163,000)
Net income (loss) (1,203,000) (1,203,000)
Ending balance, shares at Sep. 30, 2019 2 1,318,004        
Ending balance, value at Sep. 30, 2019 $ 2,000 $ 184,499,000 $ (169,785,000) $ (4,445,000) $ 10,271,000